Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of ...

It plans to invest $50 billion in the US over five years, including building its largest-ever manufacturing facility in ...

So Sir Pascal may seem an unlikely ally of Donald Trump, who as America’s president has slashed public spending on scientific ...

AstraZeneca’s chief executive has said the drugmaker is a “very American company” amid growing speculation that it will ditch ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

Also in today’s newsletter, EU warns Europe’s roads unfit for war, UBS currency derivatives and Botswana’s push on De Beers ...

Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

Glencore has axed plans to move its main stock market listing away from London, in a boost for the London Stock Exchange.

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 ...

Chris Hughes, Columnist An AstraZeneca Exit Wouldn’t Doom London If the pharma giants shifts its primary listing to New York, the focus should be developing a successor.

The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient at the ...

Note that some links may require registration or subscription. HHS Secretary Robert F. Kennedy Jr. announced that 22 projects ...